» Articles » PMID: 27074018

Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion

Overview
Journal PLoS One
Date 2016 Apr 14
PMID 27074018
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Isolation of hepatocytes from cirrhotic human livers and subsequent primary culture are important new tools for laboratory research and cell-based therapeutics in the study of hepatocellular carcinoma (HCC). Using such techniques, we have previously identified different subpopulations of human hepatocytes and among them one is showing a progressive transformation of hepatocytes in HCC-like cells. We have hypothesized that increasing the distance from the neoplastic lesion might affect hepatocyte function and transformation capacity. However, limited information is available in comparing the growth and proliferation of human hepatocytes obtained from different areas of the same cirrhotic liver in relation to their distance from the HCC lesion. In this study, hepatocytes from 10 patients with cirrhosis and HCC undergoing surgical resections from specimens obtained at a proximal (CP) and distal (CD) distance from the HCC lesion were isolated and placed in primary culture. CP hepatocytes (CP-Hep) were isolated between 1 to 3 cm (leaving at least 1cm margin to avoid cancer cells and/or satellite lesions), while CD hepatocytes (CD-Hep) were isolated from more than 5 cm or from the contralateral-lobe. A statistical model was built to analyze the proliferation rates of these cells and we evaluated expression of HCC markers (Glypican-3 (GPC3), αSmooth Muscle Actin (α-SMA) and PCNA). We observed a significant difference in proliferation and in-vitro growth showing that CP-Hep had a proliferation pattern and rate significantly different than CD-Hep. Based on these data, this model can provide information to predict growth of human hepatocytes in primary culture in relation to their pre-cancerous state with significant differences in the HCC markers expression. This model provides an important innovative tool for in-vitro analysis of HCC.

Citing Articles

Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients.

Mauro M, Ugo P, Walton Z, Ali S, Rastellini C, Cicalese L Int J Mol Sci. 2023; 24(13).

PMID: 37446098 PMC: 10342088. DOI: 10.3390/ijms241310922.


Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies.

Mossenta M, Busato D, Dal Bo M, Macor P, Toffoli G Int J Mol Sci. 2022; 23(17).

PMID: 36077433 PMC: 9456072. DOI: 10.3390/ijms231710038.


Nuclear G protein-coupled oestrogen receptor (GPR30) predicts poor survival in patients with ovarian cancer.

Zhu C, Xiong W, Wang M, Yang J, Shi H, Chen H J Int Med Res. 2017; 46(2):723-731.

PMID: 29239277 PMC: 5971494. DOI: 10.1177/0300060517717625.


Role of Glypican-3 in the growth, migration and invasion of primary hepatocytes isolated from patients with hepatocellular carcinoma.

Montalbano M, Rastellini C, McGuire J, Prajapati J, Shirafkan A, Vento R Cell Oncol (Dordr). 2017; 41(2):169-184.

PMID: 29204978 DOI: 10.1007/s13402-017-0364-2.


Oxidative Stress Induces an Interactive Decline in Wnt and Nrf2 Signaling in Degenerating Retinal Pigment Epithelium.

Ebrahimi K, Cano M, Rhee J, Datta S, Wang L, Handa J Antioxid Redox Signal. 2017; 29(4):389-407.

PMID: 29186981 PMC: 6025703. DOI: 10.1089/ars.2017.7084.

References
1.
Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio G . Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006; 243(2):229-35. PMC: 1448919. DOI: 10.1097/01.sla.0000197706.21803.a1. View

2.
Xu Y, Zhao W, Xu J, Li J, Hong Z, Yin Z . Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2. Oncotarget. 2016; 7(8):8866-78. PMC: 4891010. DOI: 10.18632/oncotarget.6839. View

3.
Zhang X, Jia Q, Lv L, Deng T, Gao J . Tumorspheres Derived from HCC Cells are Enriched with Cancer Stem Cell-like Cells and Present High Chemoresistance Dependent on the Akt Pathway. Anticancer Agents Med Chem. 2015; 15(6):755-63. DOI: 10.2174/1871520615666150202111721. View

4.
Ma S, Yang J, Li J, Song J . The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma. Tumour Biol. 2015; 37(6):7405-12. DOI: 10.1007/s13277-015-4582-9. View

5.
Wilkening S, Stahl F, Bader A . Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos. 2003; 31(8):1035-42. DOI: 10.1124/dmd.31.8.1035. View